ctrl K

Watchlist Price Alert

Freeline Therapeutics (FRLN)

NASDAQ: FRLN · Real-Time Price · USD

6.49

0.01 (0.15%)

At close: Feb 16, 2024, 8:37 PM

Freeline Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	47.28M	117.66M	229.97M	73.7M	16.05M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	1.33M	-377K	n/a	n/a	n/a
Other Long-Term Assets	3.46M	2.92M	1.8M	1.03M	275K
Receivables	1.23M	2.21M	16.11M	11.5M	8.99M
Inventory	17.64M	6.42M	3.08M	842K	616K
Other Current Assets	1.47M	2M	9.01M	3M	431K
Total Current Assets	67.63M	128.29M	258.18M	89.05M	26.09M
Property-Plant & Equipment	15.02M	9.91M	8.61M	7.27M	5.73M
Goodwill & Intangibles	-1.33M	8K	23K	43K	38K
Total Long-Term Assets	19.01M	12.83M	10.44M	8.34M	6.04M
Total Assets	86.64M	141.13M	268.61M	97.39M	32.13M
Account Payables	10.06M	5.19M	8.09M	5.82M	1.62M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	2.66M	n/a	n/a	n/a	n/a
Other Current Liabilities	18.25M	15.5M	10.72M	6.62M	7.54M
Total Current Liabilities	30.97M	20.68M	18.81M	12.43M	9.16M
Long-Term Debt	3.26M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	3.26M	n/a	n/a	n/a	n/a
Total Liabilities	34.23M	20.68M	18.81M	12.43M	9.16M
Total Debt	5.92M	n/a	n/a	n/a	n/a
Common Stock	137K	137K	155K	n/a	n/a
Retained Earnings	-445.35M	-356.38M	-215.99M	-119.67M	-65.76M
Comprehensive Income	-3.15M	9.47M	9.34M	-3M	-2.85M
Shareholders Equity	52.41M	120.44M	249.8M	84.96M	22.97M
Total Investments	1.33M	-377K	n/a	n/a	n/a